JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sissons, J.
Right arrow Articles by Khan, N. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sissons, J.
Right arrow Articles by Khan, N. A.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, July 2006, p. 2595-2600, Vol. 44, No. 7
0095-1137/06/$08.00+0     doi:10.1128/JCM.00144-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Use of In Vitro Assays To Determine Effects of Human Serum on Biological Characteristics of Acanthamoeba castellanii

James Sissons,1 Selwa Alsam,1 Monique Stins,2 Antonio Ortega Rivas,3 Jacob Lorenzo Morales,3 Jane Faull,1 and Naveed Ahmed Khan1*

School of Biological and Chemical Sciences, Birkbeck College, University of London, London, England,1 Pediatric Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland,2 Department of Parasitology, La Laguna University, La Laguna, Canary Islands, Spain3

Received 23 January 2006/ Returned for modification 26 April 2006/ Accepted 6 May 2006

Normal human serum inhibits Acanthamoeba (encephalitis isolate) binding to and cytotoxicity of human brain microvascular endothelial cells, which constitute the blood-brain barrier. Zymographic assays revealed that serum inhibits extracellular protease activities of acanthamoebae. But it is most likely that inhibition of specific properties of acanthamoebae is a consequence of the initial amoebicidal-amoebistatic effects induced by serum. For example, serum exhibited amoebicidal effects; i.e., up to 50% of the exposed trophozoites were killed. The residual subpopulation, although viable, remained static over longer incubations. Interestingly, serum enhanced the phagocytic ability of acanthamoebae, as measured by bacterial uptake. Overall, our results demonstrate that human serum has inhibitory effects on Acanthamoeba growth and viability, protease secretions, and binding to and subsequent cytotoxicity for brain microvascular endothelial cells. Conversely, Acanthamoeba phagocytosis was stimulated by serum.


* Corresponding author. Mailing address: School of Biological and Chemical Sciences, Birkbeck, College University of London, London WC1E 7HX, England. Phone: 44-(0)207-079-0797. Fax: 44-(0)207-631-6246. E-mail: n.khan{at}sbc.bbk.ac.uk.


Journal of Clinical Microbiology, July 2006, p. 2595-2600, Vol. 44, No. 7
0095-1137/06/$08.00+0     doi:10.1128/JCM.00144-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2006 by the American Society for Microbiology. All rights reserved.